Two drugs newly marketed in the US, Ponesimod for treatment of multiple sclerosis and Voclosporin for treatment of lupus nephritis, have been added to the QTdrugs list in the Possible Risk of TdP category. They will also be added to the list of Drugs to Avoid for patients with congenital long QT syndrome.
        Loading Conversation 
    
    
            
 
                                 
                                 
                                 
                                 Print
Print Share
Share RSS
RSS Donate
Donate 
    




